NRG Oncology activated FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps, or NRG-CC005), a large, randomized trial of surveillance colonoscopy for participants with a first-time diagnosis of 1 or 2 adenomas.
Participants in the study will be assigned to having their next colonoscopy exam at 5 years and at 10 years or their next colonoscopy exam at 10 years. The study is expected to enroll 9,500 participants (about 4,750 people in each study group).
The primary objective of the study is to determine when people who had 1 or 2 small benign polyps removed during colonoscopy should have their repeat colonoscopy exam.
Participants in FORTE are also being asked to submit blood, stool, and tissues from polyps to support research into how colorectal cancer develops from a polyp.
FORTE is being conducted through NCORP, in conjunction with members of the NCTN. The trial will be led by NRG Oncology with the participation of other network organizations: Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group, and SWOG.
